HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Immunicon Corporation (NASDAQ:IMMC) announced today that the Nasdaq Stock Market has approved its application to transfer the listing of its common stock to the Nasdaq Capital Market. Immunicon’s common stock began trading on the Nasdaq Capital Market, and ceased trading on the Nasdaq Global Market, at the opening of business today.
